Mediating BRAF-mutant melanoma resistance
Drug Target Review
FEBRUARY 26, 2024
Her research focus is on epigenetic regulation of melanoma and other cancers as well as wound healing, ageing biology and the development of novel epigenetic therapies targeting cancers and skin diseases and she is the owner of 15 issued and pending patents relevant to her research. Dr Alani received her M.D.
Let's personalize your content